PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the risk of acute lower extremity deep vein thrombosis

Romanian Journal of Morphology and Embryology

Volumn 55, Issue 1, 2014, Pages 153-157

  Pop, Tudor Radu ^a   Vesa, Ştefan Cristian ^a   Trifa, Adrian Pavel ^a   Crişan, Sorin ^a   Buzoianu, Anca Dana ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Caprini prediction score; Deep vein thrombosis; Padua prediction score; Risk

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN;

ACUTE DISEASE; AGED; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; LEG; MALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; ROMANIA; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA; VEIN THROMBOSIS;

ACUTE DISEASE; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEG; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; ROMANIA; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 84898608731     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW; American College of Chest Physician, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 2008, 133(6 Suppl):381S-453S.
2. Severinsen MT, Johnsen SP, Tjønneland A, Overvad K, Dethlefsen C, Kristensen SR, Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study, Eur J Intern Med, 2010, 21(4):268-272.
3. Beckman MG, Hooper WC, Critchley SE, Ortel TL, Venous thromboembolism: a public health concern, Am J Prev Med, 2010, 38(4 Suppl):S495-S501.
4. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR; American College of Chest Physicians, Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 2012, 141(2 Suppl):e419S-e494S.
5. Caprini JA, Thrombosis risk assessment as a guide to quality patient care, Dis Mon, 2005, 51(2-3):70-78.
6. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P, A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score, J Thromb Haemost, 2010, 8(11): 2450-2457.
7. Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH; American College of Chest Physicians, Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 2012, 141(2 Suppl):e195S-e226S.
8. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM; American College of Chest Physicians, Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 2012, 141(2 Suppl): e227S-e277S.
9. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH, Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature, 1994, 369(6475):64-67.
10. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, Ardissino D, Palareti G, Bernardi F, The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease, Arterioscler Thromb Vasc Biol, 1997, 17(11):2418-2422.
11. Brown NJ, Murphey LJ, Srikuma N, Koschachuhanan N, Williams GH, Vaughan DE, Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen, Arterioscler Thromb Vasc Biol, 2001, 21(6):1071-1077.
12. A ZC, Yang Y, Zhang SZ, Li N, Zhang W, Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia, Asian J Androl, 2007, 9(1):57-62.
13. Wu J, Li Y, Ma H, Bai J, Chen F, Fu S, Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis, Int J Genet, 2007, 30(3):173-177.
14. Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC; NTD Collaborative Group, Neural tube defects and folate pathway genes: family-based association tests of gene-gene and geneenvironment interactions, Environ Health Perspect, 2006, 114(10):1547-1552.
15. Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG, Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients, Thromb Haemost, 2005, 94(4):750-759.
16. Heit JA, Cohen AT, Anderson FA Jr, on behalf of the VTE Impact Assessment Group, Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US, ASH Annual Meeting Abstracts, Blood, 1995, 106:A910.
17. Wakefield TW, Caprini J, Comerota AJ, Thromboembolic diseases, Curr Probl Surg, 2008, 45(12):844-899.
18. Mahan CE, Holdsworth MT, Welch SM, Borrego M, Spyropoulos AC, Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event, Thromb Haemost, 2011, 106(3):405-415.
19. Zakai NA, Wright J, Cushman M, Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score, J Thromb Haemost, 2004, 2(12):2156-2161.
20. Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW, Jaber RM, Hamill JB, Hume KM, Rubin JP, Neligan PC, Kalliainen LK, Hoxworth RE, Pusic AL, Wilkins EG, Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients, J Am Coll Surg, 2011, 212(1):105-112.
21. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA, A validation study of a retrospective venous thromboembolism risk scoring method, Ann Surg, 2010, 251(2):344-350.
22. Zhou HX, Peng LQ, Yan Y, Yi Q, Tang YJ, Shen YC, Feng YL, Wen FQ, Validation of the Caprini risk assessment model in Chinese hospitalized patients with venous thromboembolism, Thromb Res, 2012, 130(5):735-740.
23. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ, Electronic alerts to prevent venous thromboembolism among hospitalized patients, N Engl J Med, 2005, 352(10):969-977.
24. Vardi M, Ghanem-Zoubi NO, Zidan R, Yurin V, Bitterman H, Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments. J Thromb Haemost, 2013, 11(3): 467-473.